BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Ashoka University - ECPv6.18.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Ashoka University
X-ORIGINAL-URL:https://www.ashoka.edu.in
X-WR-CALDESC:Events for Ashoka University
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Asia/Kolkata
BEGIN:STANDARD
TZOFFSETFROM:+0530
TZOFFSETTO:+0530
TZNAME:IST
DTSTART:20220101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Asia/Kolkata:20230323T140000
DTEND;TZID=Asia/Kolkata:20230323T150000
DTSTAMP:20230320T034003Z
CREATED:20230320T034003Z
LAST-MODIFIED:20230320T034003Z
UID:42117-1679580000-1679583600@www.ashoka.edu.in
SUMMARY:Decoding the Intricacies of Sphingolipid and Ganglioside Metabolism in Disease Progression
DESCRIPTION:Title: Decoding the Intricacies of Sphingolipid and Ganglioside Metabolism in Disease Progression  \nAbstract: \nSphingolipids and gangliosides are bioactive lipids that apart from having a major structural role in cellular membranes display diverse signalling roles in cellular regulatory circuits including cancer hallmark processes like cell proliferation\, inflammation\, angiogenesis\, apoptosis\, and drug resistance. My group is attempting to decode the intricacies of sphingolipid and ganglioside signalling during tumor progression\, and those targeting the tumor microenvironment in response to cancer chemotherapy. In my talk\, I will show that Rapamycin-resistant TOR Complex (Target of Rapamycin) component mTORC2 regulates the sphingolipid and ganglioside metabolism during breast cancer progression through transcriptional and epigenetic regulation of UDP-Glucose Ceramide Glucosyl transferase (UGCG) which is the key enzyme bridging the sphingolipid and ganglioside metabolic pathways. In my talk\, I will also show how sphingolipids can be explored as possible prognostic and diagnostic biomarkers for different disease conditions including cancer\, inflammatory bowel disease (IBD)\, and non-alcoholic fatty liver disease (NAFLD)\, that also has therapeutic potential. Therefore\, my talk will highlight our recent efforts on deciphering sphingolipid and ganglioside mediated metabolic alterations during disease progression\, and how these metabolites can be further explored as potential therapeutic targets. \nAbout the speaker: \nUjjaini Dasgupta is an Assistant Professor at Amity Institute of Integrative Sciences and Health\, Amity University\, Haryana. She is one of the Young Investigators (YIs) selected to attend YIM 2020. She completed MSc in Biophysics and Molecular Biology from the Department of Biophysics and Molecular Biology\, University of Calcutta. PhD from Delhi University and done postdoctoral work at the University of Massachusetts.
URL:https://www.ashoka.edu.in/event/decoding-the-intricacies-of-sphingolipid-and-ganglioside-metabolism-in-disease-progression/
END:VEVENT
END:VCALENDAR